Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.7351
Delayed Data
As of 4:01pm ET
 +0.0251 / +3.54%
Today’s Change
0.26
Today|||52-Week Range
1.51
-44.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues4.3M4.7M5.4M8.5M
 
 
 
 
 
Cost of Goods Sold487.7K494.6K546.5K909.5K
 
 
 
 
 
Depreciation And Amortization140.1K149.6K117.8K111.5K
 
 
 
 
 
 
Operating ExpensesGross Income3.7M4.1M4.7M7.5M
 
 
 
 
 
General Expenses6.3M6.6M5.3M4.1M
 
 
 
 
 
Research And Development2.6M2.7M2.5M1.3M
 
 
 
 
 
Total Operating Expenses6.9M7.3M6.0M5.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.6M-2.6M-580.0K3.4M
 
 
 
 
 
Extraordinary Credit1.1M1.1M1.5M0.00
 
 
 
 
Extraordinary Charge0.000.000.00-839.3K
 
 
Pre-Tax Equity Earnings-10.0K-12.2K-2.9K0.00
 
 
 
 
Interest Expense On Debt2.2M2.2M7.5M2.6M
 
 
 
 
 
Other Expenses708.00-37.3K-39.9K-12.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-3.7M-6.7M-59.5K
 
 
 
 
 
Income Taxes-436.1K0.000.000.00
 
 
Minority Interest-174.00-241.00-116.00-159.00
 
 
 
 
 
Discontinued Operations758.6K0.000.000.00
 
 
Net Income-2.5M-3.7M-6.7M-59.4K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS154.6M155.3M155.4M155.5M
 
 
 
 
 
Shares To Calculate EPS Diluted154.6M155.3M155.4M155.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.04$0.00
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.04-$0.00